UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

600 Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?

Journal of hepatology, 2004, Vol.40, p.176-176

2004

Volltextzugriff (PDF)

Artificial blood chimerism and graft-versus-host disease after liver transplantation

International Congress series, 2006-04, Vol.1288, p.840-842

2006

Volltextzugriff (PDF)

The beneficial effects of non-selective betabockers in secondary prophylaxis are most pronounced in patients without refractory ascites

Journal of hepatology, 2018-04, Vol.68, p.S730-S731

2018

Volltextzugriff (PDF)

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.966-979

2018

Volltextzugriff (PDF)

The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis

Digestive diseases and sciences, 2006-02, Vol.51 (2), p.338-345

2006

Volltextzugriff (PDF)

Elevated serum levels of sFas in acute viral hepatitis

European journal of gastroenterology & hepatology, 2001-12, Vol.13 (12), p.1507-1508

2001

Volltextzugriff (PDF)

Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?

Wiener medizinische Wochenschrift, 2006-04, Vol.156 (7-8), p.216-222

2006

Volltextzugriff (PDF)

Expression of various histologic molecular Correlation with clinical characteristics and survival

Journal of hepatology, 2003-04, Vol.38, p.83-83

2003

Volltextzugriff (PDF)

Failure to detect fetal microchimerism in patients with primary biliary cirrhosis

Journal of hepatology, 2000, Vol.32, p.130-130

2000

Volltextzugriff (PDF)

Graft versus Host Disease after Orthotopic Liver Transplantation Documented by Analysis of Short Tandem Repeat Polymorphisms

Digestion, 2006-01, Vol.74 (3-4), p.169-173

2006

Volltextzugriff (PDF)

Hepatic pathology in C282Y/H63D compound heterozygotes

Journal of hepatology, 2000, Vol.32, p.133-133

2000

Volltextzugriff (PDF)

Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation

European journal of gastroenterology & hepatology, 2000-08, Vol.12 (8), p.941-948

2000

Volltextzugriff (PDF)

Hepatocellular carcinoma in Central Europe: prognostic features and survival

Gut, 2001-01, Vol.48 (1), p.103-109

2001

Volltextzugriff (PDF)

Hepatocellular carcinoma - survival and clinical characteristics in relation to various histologic molecular markers in Western patients

Liver international, 2005-02, Vol.25 (1), p.62-69

2005

Volltextzugriff (PDF)

Hereditary Hemochromatosis as a Risk Factor for Joint Replacement Surgery

The American journal of medicine, 2010-07, Vol.123 (7), p.659-662

2010

Volltextzugriff (PDF)

HGV in patients with autoimmune hepatitis: anti-E2 antibodies and HGV-RNA in serum

Journal of hepatology, 1998, Vol.28, p.226-226

1998

Volltextzugriff (PDF)

Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis

Digestive diseases and sciences, 2002-09, Vol.47 (9), p.1909-1914

2002

Volltextzugriff (PDF)

Liver pathology in compound heterozygous patients for hemochromatosis mutations

Liver (Copenhagen), 2002-08, Vol.22 (4), p.295-301

2002

Volltextzugriff (PDF)

NutritionDay in European hospitals: Risikofaktoren für eine Mangelernährung bei Patienten älter als 75 Jahre

Aktuelle Ernährungsmedizin, 2007, Vol.32 (3)

2007

Volltextzugriff (PDF)

Outcome after the use of SX-ELLA Danis bleeding stents for refractory variceal bleeding- a Vienna Multicenter Experience

Journal of hepatology, 2018-04, Vol.68, p.S729-S730

2018

Volltextzugriff (PDF)

Pilot study: rapamycin in advanced hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2010-09, Vol.32 (6), p.763-768

2010

Volltextzugriff (PDF)

Prevalence of hepatitis G-virus infection in alcohol abusing patients with and without liver cirrhosis

Wiener Klinische Wochenschrift, 1998-10, Vol.110 (19), p.686

1998

Volltextzugriff (PDF)

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: HCC: prognostic factors for sorafenib therapy

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.949-959

2011

Volltextzugriff (PDF)

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.949-959

2011

Volltextzugriff (PDF)

Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis

Gastroenterology (New York, N.Y. 1943), 2003-10, Vol.125 (4), p.1042-1052

2003

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

600 Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?

Artificial blood chimerism and graft-versus-host disease after liver transplantation

The beneficial effects of non-selective betabockers in secondary prophylaxis are most pronounced in patients without refractory ascites

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis

Elevated serum levels of sFas in acute viral hepatitis

Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?

Expression of various histologic molecular Correlation with clinical characteristics and survival

Failure to detect fetal microchimerism in patients with primary biliary cirrhosis

Graft versus Host Disease after Orthotopic Liver Transplantation Documented by Analysis of Short Tandem Repeat Polymorphisms

Hepatic pathology in C282Y/H63D compound heterozygotes

Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation

Hepatocellular carcinoma in Central Europe: prognostic features and survival

Hepatocellular carcinoma - survival and clinical characteristics in relation to various histologic molecular markers in Western patients

Hereditary Hemochromatosis as a Risk Factor for Joint Replacement Surgery

HGV in patients with autoimmune hepatitis: anti-E2 antibodies and HGV-RNA in serum

Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis

Liver pathology in compound heterozygous patients for hemochromatosis mutations

NutritionDay in European hospitals: Risikofaktoren für eine Mangelernährung bei Patienten älter als 75 Jahre

Outcome after the use of SX-ELLA Danis bleeding stents for refractory variceal bleeding- a Vienna Multicenter Experience

Pilot study: rapamycin in advanced hepatocellular carcinoma

Prevalence of hepatitis G-virus infection in alcohol abusing patients with and without liver cirrhosis

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: HCC: prognostic factors for sorafenib therapy

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis

Aktive Filter

Suchergebnisse filtern